NewLimit

Developing epigenetic reprogramming medicines to extend human healthspan.

newlimit.comBiotechnology50 employeesUS
PrivateFounded 2021Series B (2025)Epigenetic reprogrammingDrug discoverySingle-cell genomicsmRNA therapeutics developmentHigh-throughput biological screening
Showing 12 matching jobs
Title
Head of Manufacturing
Full Time
South San Francisco, California, United States · Onsite
Scientist, Drug Product Analytical
Full Time · $130K-$170K · 1+ YOE
South San Francisco, California, United States · Onsite
Senior Scientist, mRNA engineering
Full Time · $160K-$185K · 5+ YOE
South San Francisco, California, United States · Onsite
Scientist/Senior Scientist, PK/PD Assays
Full Time · $90K-$110K · 5+ YOE
South San Francisco, California, United States · Onsite
VP, Clinical Development
Full Time
South San Francisco, California, United States · Onsite
Computational Biologist
Full Time · $130K-$170K
South San Francisco, California, United States · Onsite
Senior/Research Associate
Full Time · $75K-$100K · 2+ YOE
South San Francisco, California, United States · Onsite
Scientist/Senior Scientist, Immunology
Full Time · $130K-$180K · 2+ YOE
South San Francisco, California, United States · Onsite
Senior Research Associate, Metabolism
Full Time · $90K-$105K · 2+ YOE
South San Francisco, California, United States · Onsite
Senior Research Associate, Single Cell Technology
Full Time · $90K-$110K · 2+ YOE
South San Francisco, California, United States · Onsite
Bioinformatics Software Engineer / Analyst
Full Time · $140K-$200K
South San Francisco, California, United States · Onsite
Scientist/Senior Scientist, Vascular
Full Time · 5+ YOE
South San Francisco, California, United States · Onsite

About NewLimit

Activities
Epigenetic reprogrammingDrug discoverySingle-cell genomicsmRNA therapeutics developmentHigh-throughput biological screening
HeadquartersUS
Industries
Biotechnology
NameNewLimit
Employees50
TypePrivate
TaglineDeveloping epigenetic reprogramming medicines to extend human healthspan.
Founded2,021
Websitenewlimit.com
Latest Funding RoundSeries B
Latest Funding Year2,025
Latest Funding Amount45,000,000
Latest Investors
Kleiner PerkinsEli Lilly and Company